Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
S&P ASX 200
7,135.70
(
0.35%
)
S&P ASX All Technology
2,408.80
(
0.76%
)
Brent Oil
74.67
(
0.46%
)
US Dollar vs AUD
1.5131
(
-0.47%
)
Bitcoin
27,102.43
(
1.05%
)
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. X4 Pharmaceuticals Inc (XFOR)

  7. X4 Pharmaceuticals Inc (XFOR) Financials

XFOR

X4 Pharmaceuticals Inc

2.20
0.17 (8.37%)
Upgrade to Real-Time

X4 Pharmaceuticals Inc. (XFOR) Fundamentals
X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme.
SHARE INFORMATION
Market CapUS$ 271,300,623
Shares Outstanding122,207,488
Float88,080,000
Percent Float72.07%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 49,000
Latest Fiscal EPSUS$ -0.16
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions106
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months18,539,873
Institutional Holdings Percent63.3%
Institutional Sold Previous 3 Months6,295,051
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent0.7
Insider Sold Previous 3 Months191,868
Insider Shares Owned896,320
TRADING INFO
52 Week HighUS$ 2.41
52 Week LowUS$ 0.65
52 Week High ChangeUS$ 79.03
21 Day Moving AverageUS$ 1.8274
21 Day Extended Moving AverageUS$ 1.8498
50 Day Moving AverageUS$ 1.4187
50 Day Extended Moving AverageUS$ 1.5591
200 Day Moving AverageUS$ 1.3044
200 Day Extended Moving AverageUS$ 1.4458
10 Day Average Volume4,595,457
20 Day Average Volume5,268,648
30 Day Average Volume4,398,547
50 Day Average Volume3,710,781
Alpha-0.018914
Beta0.6824
Standard Deviation0.352299
R20.010839
7 Day Price ChangeUS$ 0.21
7 Day Percent Change10.45%
21 Day Price ChangeUS$ 0.73
21 Day Percent Change48.99%
30 Day Price ChangeUS$ 0.65
30 Day Percent Change41.4%
Month to Date Price ChangeUS$ 0.19
Month to Date Percent Change9.36%
Quarter to Date Price ChangeUS$ 1.35
Quarter to Date Percent Change155.17%
180 Day Price ChangeUS$ 0.78
180 Day Percent Change54.17%
200 Day Price ChangeUS$ 0.23
200 Day Percent Change11.56%
Year to Date Price ChangeUS$ 1.23
Year to Date Percent Change123.56%

X4 Pharmaceuticals Inc. (XFOR) Key Ratios

PROFITABILITY
EBIT Margin-100,961.2%
EBITDA Margin-41,138.8%
Pre-Tax Profit Margin-9,619.2%
Profit Margin Count-490.2%
Gross Margin100.0%
Profit Margin TOT-490.2%
INCOME STATEMENTS
RevenueUS$ 49,000
Revenue Per ShareUS$ 0.0004
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book6.90
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio5.00
Leverage Ratio2.40
Quick Ratio4.80
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 159,781,201
Price to Sales3,666.22
Price to Free Cash53.20
PE High Last 5 Years0.00
Price To Book4.60
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book6.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-40.56
Return on Equity-89.26
Return on Capital0.00

X4 Pharmaceuticals Inc. (XFOR) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOPaula S. Ragan
Employees100
Last Audit-
CIK0001501697
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address61 North Beacon Street, 4th Floor,4th Floor
4th Floor
Boston, MA 2134
Websitehttps://www.x4pharma.com
Facsimile-
Telephone+1 857 529-8300
EmailCandice.ellis@x4pharma.com
Your Recent History
NASDAQ
XFOR
X4 Pharmac..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230602 04:53:35